Our patent portfolio includes U.S. Patent No. 9,925,149, covering the core technology for the formation and manufacturing of lipid, structural nanoparticles, which is the Nanosphere Delivery System™ and extends to 16 different forms of lipid nanoparticle structures, which can be applied across healthcare sectors for vastly improved medical delivery.
US Patent No. 10,028,919, grants NanoSphere Health full ownership over the standardized delivery of cannabis into systemic circulation through phospholipid nanoparticle technology.
This delivery platform, which was recently awarded the
Frost and Sullivan 2018 Best Practices Award for Technological Innovation, makes the nanoencapsulated ingredients safer, more bioavailable and faster-acting, while also reducing adverse effects by delivering precise doses in smart nanoparticles to target sites.